Literature DB >> 16627534

Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UK.

C A Heath1, R A Barker, T F G Esmonde, P Harvey, R Roberts, P Trend, M W Head, C Smith, J E Bell, J W Ironside, R G Will, R S G Knight.   

Abstract

Between 1970 and 2003, seven cases of human dura mater-associated Creutzfeldt-Jakob disease (CJD) were identified in the UK. Furthermore, we identified a case of CJD in a porcine dura graft recipient. The mean incubation period of the human dura mater cases was 93 (range 45-177) months. The clinico-pathological features of the cases are described and compared with cases previously reported in the world literature.

Entities:  

Mesh：

Year:  2006        PMID： 16627534      PMCID： PMC2117491          DOI： 10.1136/jnnp.2005.073395

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  20 in total

1.  Diagnosis of new variant Creutzfeldt-Jakob disease.

Authors:  R G Will; M Zeidler; G E Stewart; M A Macleod; J W Ironside; S N Cousens; J Mackenzie; K Estibeiro; A J Green; R S Knight
Journal:  Ann Neurol       Date:  2000-05       Impact factor: 10.422

2.  Creutzfeldt-Jakob disease after non-commercial dura mater graft.

Authors:  M Pocchiari; C Masullo; M Salvatore; M Genuardi; S Galgani
Journal:  Lancet       Date:  1992-09-05       Impact factor: 79.321

3.  Creutzfeldt-Jakob disease with florid plaques after cadaveric dural graft in a Japanese woman.

Authors:  S Takashima; J Tateishi; Y Taguchi; H Inoue
Journal:  Lancet       Date:  1997-09-20       Impact factor: 79.321

4.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.

Authors:  J Collinge; K C Sidle; J Meads; J Ironside; A F Hill
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

5.  Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease.

Authors:  P Duffy; J Wolf; G Collins; A G DeVoe; B Streeten; D Cowen
Journal:  N Engl J Med       Date:  1974-03-21       Impact factor: 91.245

6.  Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report.

Authors:  V Thadani; P L Penar; J Partington; R Kalb; R Janssen; L B Schonberger; C S Rabkin; J W Prichard
Journal:  J Neurosurg       Date:  1988-11       Impact factor: 5.115

7.  Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study.

Authors:  S Collins; M G Law; A Fletcher; A Boyd; J Kaldor; C L Masters
Journal:  Lancet       Date:  1999-02-27       Impact factor: 79.321

8.  Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent.

Authors:  M E Bruce; R G Will; J W Ironside; I McConnell; D Drummond; A Suttie; L McCardle; A Chree; J Hope; C Birkett; S Cousens; H Fraser; C J Bostock
Journal:  Nature       Date:  1997-10-02       Impact factor: 49.962

Review 9.  Creutzfeldt-Jakob disease and lyophilised dura mater grafts: report of two cases.

Authors:  T Esmonde; C J Lueck; L Symon; L W Duchen; R G Will
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-09       Impact factor: 10.154

10.  A new variant of Creutzfeldt-Jakob disease in the UK.

Authors:  R G Will; J W Ironside; M Zeidler; S N Cousens; K Estibeiro; A Alperovitch; S Poser; M Pocchiari; A Hofman; P G Smith
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321
View more
  17 in total

1.  Dura mater graft-associated Creutzfeldt-Jakob disease: the first case in Korea.

Authors:  Hye Lim Kim; Ju Young Do; Han Jeong Cho; Yong-Chul Jeon; Seok Joo Park; Hyeo Il Ma; Jun Ho Song; Yul Lee; Hyun Choi; Kyung Chan Choi; Yong Sun Kim; Inga Zerr; Kai Kallenberg; Yun Joong Kim
Journal:  J Korean Med Sci       Date:  2011-10-27       Impact factor: 2.153

2.  Brain biopsies requiring Creutzfeldt-Jakob disease precautions in the Republic of Ireland 2005-2016.

Authors:  F M Brett; S Looby; A Chalissery; D Chen; C Heaney; J Heffernan; F Cunningham; R Howley; T Loftus; H Kearney; M A Farrell
Journal:  Ir J Med Sci       Date:  2017-08-12       Impact factor: 1.568

3.  Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review.

Authors:  Matt Stevenson; Lesley Uttley; Jeremy E Oakley; Christopher Carroll; Stephen E Chick; Ruth Wong
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

Review 4.  Prion protein scrapie and the normal cellular prion protein.

Authors:  Caroline J Atkinson; Kai Zhang; Alan L Munn; Adrian Wiegmans; Ming Q Wei
Journal:  Prion       Date:  2016       Impact factor: 3.931

5.  MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease.

Authors:  B Meissner; K Kallenberg; P Sanchez-Juan; S Ramljak; A Krasnianski; U Heinemann; S Eigenbrod; E Gelpi; B Barsic; H A Kretzschmar; W J Schulz-Schaeffer; M Knauth; I Zerr
Journal:  J Neurol       Date:  2009-01-23       Impact factor: 4.849

Review 6.  Sporadic and Infectious Human Prion Diseases.

Authors:  Robert G Will; James W Ironside
Journal:  Cold Spring Harb Perspect Med       Date:  2017-01-03       Impact factor: 6.915

7.  Clinical experience with a novel bovine collagen dura mater substitute.

Authors:  Bruno Silva Costa; George de Albuquerque Cavalcanti-Mendes; Marcelo Sartori de Abreu; Atos Alves de Sousa
Journal:  Asian J Neurosurg       Date:  2010-07

8.  Transgenic mice expressing porcine prion protein resistant to classical scrapie but susceptible to sheep bovine spongiform encephalopathy and atypical scrapie.

Authors:  Juan Carlos Espinosa; María Eugenia Herva; Olivier Andréoletti; Danielle Padilla; Caroline Lacroux; Hervé Cassard; Isabelle Lantier; Joaquin Castilla; Juan Maria Torres
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

9.  Porcine prion protein amyloid.

Authors:  Per Hammarström; Sofie Nyström
Journal:  Prion       Date:  2015       Impact factor: 3.931

10.  Graft-related disease progression in dura mater graft-associated Creutzfeldt-Jakob disease: a cross-sectional study.

Authors:  Kenji Sakai; Tsuyoshi Hamaguchi; Moeko Noguchi-Shinohara; Ichiro Nozaki; Ichiro Takumi; Nobuo Sanjo; Yosikazu Nakamura; Tetsuyuki Kitamoto; Nobuhito Saito; Hidehiro Mizusawa; Masahito Yamada
Journal:  BMJ Open       Date:  2013-08-23       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.